米国の腎除神経カテーテル市場規模、シェア、動向分析レポート：製品別、最終用途別、セグメント別予測、2025年～2033年

米国の腎除神経カテーテル市場サマリー

米国の腎除神経カテーテル市場規模は、2025年に2,320万米ドルと推計され、2033年には1億8,270万米ドルに達すると予測され、2025年から2033年までのCAGRは29.43%で成長すると予測されます。この成長の背景には、高血圧の有病率の上昇と薬理学的治療の限界に対する意識の高まり、腎除神経の安全性と有効性を裏付ける臨床エビデンスの増加、最近のFDA承認など規制面での有利な進展があり、市場導入がさらに加速しています。

2024年10月にNational Center for Health StatisticsとNational Health and Nutrition Examination Surveyが発表したデータによると、米国成人の高血圧有病率は18～39歳で23.4％、40～59歳で52.5％に上昇し、60歳以上では2021年8月から2023年8月までの期間に71.6％に達しました。

高血圧の高い有病率は、米国の腎除神経カテーテル産業の主要な促進要因の一つです。さらに、複数の降圧薬に十分に反応しない治療抵抗性高血圧に苦しむ患者も増えています。このような疾病の広範な負担は、長期的な血圧コントロールに非薬物療法的アプローチを提供する腎除神経のような代替治療介入に対する強い臨床的ニーズを生み出しています。認知度と診断率が向上するにつれて、RDN手技の対象となる患者層は拡大し、市場の需要をさらに押し上げると予想されます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 米国の腎神経除去カテーテル市場の変数、動向、および範囲

• 市場系統の見通し
  • 補助市場の見通し
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
  • 市場機会分析
  • 市場課題分析
• 米国の腎神経除去カテーテル市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析

第4章 米国の腎神経除去カテーテル市場：製品推定・動向分析

• セグメントダッシュボード
• 米国の腎神経除去カテーテル市場の製品変動分析
• 米国の腎神経除去カテーテル市場規模と動向分析（製品別、2025～2033年）
• 高周波（RF）アブレーションカテーテル
• 超音波アブレーションカテーテル

第5章 米国の腎神経除去カテーテル市場：最終用途の推定・動向分析

• セグメントダッシュボード
• 米国の腎神経除去カテーテル市場の最終用途変動分析
• 米国の腎神経除去カテーテル市場規模と動向分析（最終用途別、2025～2033年）
• 病院
• その他

第6章 競合情勢

• 市場参入企業の分類
• 主要企業プロファイル
  • Recor Medical, Inc.（Otsuka Medical Devices Co., Ltd.）
  • Medtronic
  • Boston Scientific Corporation
  • MicroPort Scientific Corporation
  • EnligHTN, St. Jude Medical（Abbott Laboratories）
  • Ablative Solutions, Inc.

List of Tables

• Table 1. List of Secondary Sources
• Table 2. List of Abbreviations
• Table 3. U.S. Renal Denervation Catheter Market, by Product, 2025 - 2033 (USD Million)
• Table 4. U.S. Renal Denervation Catheter Market, by End Use, 2025 - 2033 (USD Million)
• Table 5. Participant's Overview
• Table 6. Financial Performance
• Table 7. Product Benchmarking
• Table 8. Strategic Initiatives

List of Figures

• Fig. 1 Information Procurement
• Fig. 2 Primary Research Pattern
• Fig. 3 Market Research Approaches
• Fig. 4 Value Chain-Based Sizing & Forecasting
• Fig. 5 Market Formulation & Validation
• Fig. 6 U.S. Renal Denervation Catheter Market, Market Segmentation
• Fig. 7 Market Driver Analysis (Current & Future Impact)
• Fig. 8 Market Restraint Analysis (Current & Future Impact)
• Fig. 9 Market Opportunity Analysis (Current & Future Impact)
• Fig. 10 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• Fig. 11 Porter's Five Forces Analysis
• Fig. 12 Regional Marketplace: Key Takeaways
• Fig. 13 U.S. Renal Denervation Catheter Market, for Product, 2025 - 2033 (USD Million)
• Fig. 14 U.S. Renal Denervation Catheter Market, for Radiofrequency (RF) Ablation Catheters, 2025 - 2033 (USD Million)
• Fig. 15 U.S. Renal Denervation Catheter Market, for Ultrasound Ablation Catheters, 2025 - 2033 (USD Million)
• Fig. 16 U.S. Renal Denervation Catheter Market, for End Use, 2025 - 2033 (USD Million)
• Fig. 17 U.S. Renal Denervation Catheter Market, for Hospitals, 2025 - 2033 (USD Million)
• Fig. 18 U.S. Renal Denervation Catheter Market, for Other, 2025 - 2033 (USD Million)

U.S. Renal Denervation Catheter Market Summary

The U.S. renal denervation catheter market size was estimated at USD 23.20 million in 2025 and is projected to reach USD 182.70 million by 2033, growing at a CAGR of 29.43% from 2025 to 2033. The growth is driven by the rising prevalence of hypertension and growing awareness about the limitations of pharmacological treatments, increasing clinical evidence supporting the safety and efficacy of renal denervation, and favorable regulatory advancements, such as the recent FDA approval, are further accelerating market adoption.

According to data released by the National Center for Health Statistics and the National Health and Nutrition Examination Survey in October 2024, the prevalence of hypertension among U.S. adults was 23.4% for those aged 18-39, rising to 52.5% for individuals aged 40-59, and reaching 71.6% for those aged 60 and older during the period from August 2021 to August 2023.

The high prevalence of hypertension is one of the primary drivers for the U.S. renal denervation catheter industry. In addition, a growing subset of patients suffers from treatment-resistant hypertension, which does not respond adequately to multiple antihypertensive medications. This widespread burden of disease creates a strong clinical need for alternative therapeutic interventions, such as renal denervation, which offers a non-pharmacological approach to long-term blood pressure control. As awareness and diagnosis rates improve, the eligible patient pool for RDN procedures is expected to expand, further propelling market demand.

U.S. Renal Denervation Catheter Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2025 to 2033. For this study, Grand View Research has segmented the U.S. renal denervation catheter market report based on product and end use:

• Product Outlook (Revenue, USD Million, 2025 - 2033)
• Radiofrequency (RF) Ablation Catheters
• Ultrasound Ablation Catheters
• End Use Outlook (Revenue, USD Million, 2025 - 2033)
• Hospitals
• Other

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. End Use
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
  • 1.5.5. Information Analysis
  • 1.5.6. Data Analysis Models
• 1.6. Market Formulation & Data Visualization
• 1.7. Model Details
  • 1.7.1. Commodity Flow Analysis
• 1.8. List of Secondary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Renal Denervation Catheter Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising prevalence of hypertension as a leading cause of cardiovascular disease
    • 3.2.1.2. Growing regulatory approvals
    • 3.2.1.3. Increasing awareness about hypertension management market restraint analysis
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Potential adverse events and complications associated with renal denervation catheters
    • 3.2.2.2. Shortage of cardiologists
  • 3.2.3. Market Opportunities Analysis
    • 3.2.3.1. Growing clinical trials for renal denervation catheters
    • 3.2.3.2. Improving reimbursement for renal denervation catheters
    • 3.2.3.3. Strategic investments for renal denervation product portfolio expansion
    • 3.2.3.4. Advancing multielectrode RDN catheters with dual access capabilities
  • 3.2.4. Market Challenges Analysis
    • 3.2.4.1. Stringent regulations
• 3.3. U.S. Renal Denervation Catheter Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape

Chapter 4. U.S. Renal Denervation Catheter Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. Renal Denervation Catheter Market Product Movement Analysis
• 4.3. U.S. Renal Denervation Catheter Market Size & Trend Analysis, by Product, 2025 to 2033 (USD Million)
• 4.4. Radiofrequency (RF) Ablation Catheters
  • 4.4.1. Radiofrequency (RF) Ablation Catheters Market Revenue Estimates and Forecasts, 2025 - 2033 (USD Million)
• 4.5. Ultrasound Ablation Catheters
  • 4.5.1. Ultrasound Ablation Catheters U.S. Renal Denervation Catheter Market Revenue Estimates and Forecasts, 2025 - 2033 (USD Million)

Chapter 5. U.S. Renal Denervation Catheter Market: End Use Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. U.S. Renal Denervation Catheter Market End Use Movement Analysis
• 5.3. U.S. Renal Denervation Catheter Market Size & Trend Analysis, by End Use, 2025 to 2033 (USD Million)
• 5.4. Hospitals
  • 5.4.1. Hospitals U.S. Renal Denervation Catheter Market Revenue Estimates and Forecasts, 2025 - 2033 (USD Million)
• 5.5. Other
  • 5.5.1. Other U.S. Renal Denervation Catheter Market Revenue Estimates and Forecasts, 2025 - 2033 (USD Million)

Chapter 6. Competitive Landscape

• 6.1. Market Participant Categorization
• 6.2. Key Company Profiles
  • 6.2.1. Recor Medical, Inc. (Otsuka Medical Devices Co., Ltd.)
    • 6.2.1.1. Company Overview
    • 6.2.1.2. Financial Performance
    • 6.2.1.3. Product Benchmarking
    • 6.2.1.4. Strategic Initiatives
  • 6.2.2. Medtronic
    • 6.2.2.1. Company Overview
    • 6.2.2.2. Financial Performance
    • 6.2.2.3. Product Benchmarking
    • 6.2.2.4. Strategic Initiatives
  • 6.2.3. Boston Scientific Corporation
    • 6.2.3.1. Company Overview
    • 6.2.3.2. Financial Performance
    • 6.2.3.3. Product Benchmarking
    • 6.2.3.4. Strategic Initiatives
  • 6.2.4. MicroPort Scientific Corporation
    • 6.2.4.1. Company Overview
    • 6.2.4.2. Financial Performance
    • 6.2.4.3. Product Benchmarking
    • 6.2.4.4. Strategic Initiatives
  • 6.2.5. EnligHTN, St. Jude Medical (Abbott Laboratories)
    • 6.2.5.1. Company Overview
    • 6.2.5.2. Financial Performance
    • 6.2.5.3. Product Benchmarking
    • 6.2.5.4. Strategic Initiatives
  • 6.2.6. Ablative Solutions, Inc.
    • 6.2.6.1. Company Overview
    • 6.2.6.2. Financial Performance
    • 6.2.6.3. Product Benchmarking
    • 6.2.6.4. Strategic Initiatives